Bio-Rad Laboratories, Inc. (BIO)

304,13 -6,05 (-1,95%) Börsenschluss: 04:00PM EST

Bio-Rad Laboratories, Inc.

1000 Alfred Nobel Drive
Hercules, CA 94547
United States
510 724 7000
https://www.bio-rad.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 8.000

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Norman D. Schwartz	Chairman, CEO & President	2,13M	15,23M	1950
Dr. Andrew J. Last Ph.D.	Executive VP & COO	1,12M	N/A	1960
Dr. Simon May	Executive VP & President of the Life Science Group	787,76k	N/A	N/A
Ms. Dara Grantham Wright	Executive VP & President of Clinical Diagnostics Group	849,53k	N/A	1976
Ms. Tania DeVilliers	Senior Director, Corporate Controller & Interim Principal Accounting Officer	N/A	N/A	1973
Mr. Yong Chung	Vice President of Investor Relations	N/A	N/A	N/A
Mr. Timothy S. Ernst	Executive VP, General Counsel & Secretary	N/A	N/A	1960
Matthew Werner	Senior Vice President and Chief Compliance & Privacy Officer	N/A	N/A	N/A
Colleen Corey	Executive Vice President of Global Human Resources	N/A	N/A	N/A
Mr. Michael Crowley	Executive Vice President of Global Commercial Operations	974,94k	1,85M	1962

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Corporate Governance

Bio-Rad Laboratories, Inc.s ISS Governance QualityScore, Stand 1. Dezember 2023, lautet 10. Die grundlegenden Scores sind Audit: 10, Vorstand: 10, Shareholderrechte: 10, Kompensation: 8.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.